Announcements
- Biotalys Starts Field Trials for Second Biofungicide
- Biotalys Appoints Laura J. Meyer to Board of Directors
- Results of the Ordinary and Extraordinary Shareholders’ Meeting
- Results of the Special Shareholders’ Meeting
- Invitation to the ordinary general shareholders meeting and an extraordinary shareholders meeting
- Biotalys and Novonesis announce manufacturing and commercialisation partnership for EVOCA NG
- Invitation to a Special Shareholders’ Meeting
- Biotalys Reports Full-Year 2023 Financial Results and Business Highlights
- Biotalys Enters into Academic Collaborations with Key Scientific Leaders in Europe and U.S.
- Information on the total number of voting rights and shares
More ▼
Key statistics
As of last trade, Biotalys NV (86C:BER) traded at 3.02, 17.51% above the 52 week low of 2.57 set on Mar 14, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.79 |
---|---|
High | 3.02 |
Low | 2.79 |
Bid | 2.88 |
Offer | 3.16 |
Previous close | 2.80 |
Average volume | 0.00 |
---|---|
Shares outstanding | 32.16m |
Free float | 17.61m |
P/E (TTM) | -- |
Market cap | 90.04m EUR |
EPS (TTM) | -0.6499 EUR |
Data delayed at least 15 minutes, as of May 15 2024 18:33 BST.
More ▼